Digital pathology analysis quantifies spatial heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 immune markers in triple-negative breast cancer H Mi, C Gong, J Sulam, EJ Fertig, AS Szalay, EM Jaffee, V Stearns, ... Frontiers in physiology 11, 583333, 2020 | 52 | 2020 |
Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers H Mi, S Sivagnanam, CB Betts, SM Liudahl, EM Jaffee, LM Coussens, ... Cancer Research 82 (23), 4359–4372, 2022 | 36 | 2022 |
Multi-scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma H Mi, WJ Ho, M Yarchoan, AS Popel Frontiers in Immunology 13, 1986, 2022 | 35 | 2022 |
Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model A Ruiz-Martinez, C Gong, H Wang, RJ Sové, H Mi, H Kimko, AS Popel PLoS computational biology 18 (7), e1010254, 2022 | 29 | 2022 |
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture H Mi, TJ Bivalacqua, M Kates, R Seiler, PC Black, AS Popel, AS Baras Cell Reports Medicine 2 (9), 2021 | 29 | 2021 |
Sparse multi-modal graph transformer with shared-context processing for representation learning of giga-pixel images R Nakhli, PA Moghadam, H Mi, H Farahani, A Baras, B Gilks, ... Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern …, 2023 | 14* | 2023 |
Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery S Zhang, A Deshpande, BK Verma, H Wang, H Mi, L Yuan, WJ Ho, ... Cancer Research, 2024 | 7* | 2024 |
Quantifying Intratumoral heterogeneity and Immunoarchitecture generated in-silico by a spatial quantitative systems pharmacology model M Nikfar, H Mi, C Gong, H Kimko, AS Popel Cancers 15 (10), 2750, 2023 | 6 | 2023 |
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer H Mi, R Varadhan, AM Cimino-Mathews, LA Emens, CA Santa-Maria, ... bioRxiv, 2023 | 1 | 2023 |
Integrating spatial multi-omics data with spatial quantitative pharmacology (spQSP) model to simulate human neoadjuvant immunotherapy clinical trial of hepatocellular carcinoma S Zhang, A Deshpande, BK Verma, H Wang, H Mi, L Yuan, WJ Ho, ... Cancer Research 84 (6_Supplement), 2312-2312, 2024 | | 2024 |
Decoding the complete organelle genomic architecture of Stewartia gemmata: an early-diverging species in Theaceae D Liu, Z Zhang, Y Hao, M Li, H Yu, X Zhang, H Mi, L Cheng, Y Zhao BMC genomics 25 (1), 114, 2024 | | 2024 |
A digital pathology platform to quantify the spatial heterogeneity and patterns of immune markers in pathology specimens from triple-negative breast cancer H Mi Johns Hopkins University, 2020 | | 2020 |